Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
73 hedge funds and large institutions have $422M invested in Applied Therapeutics in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 6 reducing their positions, and 11 closing their positions.
633% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 6
82% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 11
34% more capital invested
Capital invested by funds: $315M → $422M (+$107M)
14% more funds holding
Funds holding: 64 → 73 (+9)
9.37% more ownership
Funds ownership: 43.92% → 53.29% (+9.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.2M |
| 2 |
BlackRock
New York
|
+$12.5M |
| 3 |
BAMCO Inc
New York
|
+$6.84M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$6.81M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$6.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.6M |
| 2 |
O
OrbiMed
New York
|
-$4.28M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$4.09M |
| 4 |
Millennium Management
New York
|
-$3.16M |
| 5 |
OC
Oppenheimer & Co
New York
|
-$2.41M |
APLT Hedge Fund Activity: Q2 2020 in Review
73 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q2 2020, worth a combined $422M — up 34% from $315M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new APLT positions and 11 closed out — a net gain of 9 holders — while 44 added to existing stakes and 6 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $32.2M. The largest seller was Point72 Asset Management, cutting an estimated $12.6M.
- 73 institutional investors held Applied Therapeutics (APLT) as of Q2 2020, up from 64 in Q1 2020.
- Funds reported $422M of Applied Therapeutics stock for Q2 2020, up 34% quarter-over-quarter.
- 20 funds opened new Applied Therapeutics positions in Q2 2020 and 11 closed out, a net change of +9 holders.
- The largest Applied Therapeutics buyer in Q2 2020 was Fidelity Investments, an estimated $32.2M added.
- The largest Applied Therapeutics seller in Q2 2020 was Point72 Asset Management, an estimated $12.6M sold.
Based on aggregated 13F filings for Q2 2020.